SEC Form 4 · accession 0001013606-15-000029
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert D Mitchell
Officer — President
Period of report
Apr 7, 2015
Accepted (ET)
Apr 7, 2015 · 2:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 1, 2015 | S | 30,000 | $17.00 | D | 264,141 | D | |
| Common Stock | Apr 6, 2015 | S | 15,000 | $18.00 | D | 249,141 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
The sales reported in this From 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2015. The sales reported in this Form 4 represent all shares subject to the Rule 10b5-1 trading plan. Due to an administrative oversight the sale made on April 1, 2015 is being reported late.